Yee Ling Wu Selected Research

Asthma (Bronchial Asthma)

1/2017

Intrinsic transcriptional heterogeneity in B cells controls early class switching to IgE.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yee Ling Wu Research Topics

Disease

10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 06/2007
7	Autoimmune Diseases (Autoimmune Disease) 05/2023 - 06/2007
2	Myositis (Idiopathic Inflammatory Myopathies) 05/2023 - 02/2023
2	Dermatomyositis (Dermatopolymyositis) 02/2023 - 01/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 08/2012
1	Hereditary Complement Deficiency Diseases 05/2023
1	Arthritis (Polyarthritis) 05/2023
1	Fatigue 02/2023
1	Inclusion Body Myositis 02/2023
1	Polymyositis 02/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2021
1	Hypertension (High Blood Pressure) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Atherosclerosis 01/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019
1	Asthma (Bronchial Asthma) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Hemolytic Anemia 01/2016
1	Infections 01/2016
1	Virus Diseases (Viral Diseases) 09/2014
1	Breast Neoplasms (Breast Cancer) 04/2013
1	Neoplasms (Cancer) 04/2013
1	Rheumatoid Arthritis 05/2012

Drug/Important Bio-Agent (IBA)

8	Complement System Proteins (Complement)IBA 05/2023 - 01/2016
6	Complement C4 (Complement Component 4)IBA 05/2023 - 06/2007
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2007
3	Complement C4bIBA 01/2021 - 05/2012
3	AntibodiesIBA 01/2016 - 09/2014
3	Complement C4aIBA 08/2012 - 01/2011
2	Immunoglobulin G (IgG)IBA 01/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 04/2013
1	AutoantibodiesIBA 02/2023
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2023
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 02/2023
1	Codon (Codons)IBA 01/2021
1	HLA-DRB1*04 antigenIBA 01/2021
1	Antiphospholipid AntibodiesIBA 01/2019
1	Atorvastatin (Lipitor)FDA Link 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2019
1	Complement Factor H (Factor H)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2017
1	AntigensIBA 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2016
1	Single-Stranded DNA (DNA, Single Stranded)IBA 09/2014
1	CytidineIBA 09/2014
1	UracilIBA 04/2013
1	NucleotidesIBA 04/2013
1	Blood Proteins (Serum Proteins)IBA 08/2012
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Toll-Like Receptor 7IBA 09/2010
1	HLA-DRB1*03:01 antigenIBA 04/2009

Therapy/Procedure

1	Therapeutics 01/2019